PMV Pharmaceuticals, Inc. (PMVP)
NASDAQ: PMVP · Real-Time Price · USD
1.370
+0.040 (3.01%)
Sep 28, 2026, 3:15 PM EDT - Market open
PMV Pharmaceuticals Market Cap
PMV Pharmaceuticals has a market cap or net worth of $103.45 million as of September 28, 2026. Its market cap has increased by 31.90% in one year.
Market Cap
103.45M
Enterprise Value
24.24M
1-Year Change
31.90%
Ranking
Category
Stock Price
$1.37
ChartMarket Cap Chart
Since the IPO on September 25, 2020, PMV Pharmaceuticals's market cap has decreased from $1.61B to $103.45M, a decrease of -93.59%. That is a compound annual growth rate of -36.68%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 28, 2026 | 103.45M | 55.53% |
| Dec 31, 2025 | 66.51M | -14.88% |
| Dec 31, 2024 | 78.14M | -50.73% |
| Dec 29, 2023 | 158.59M | -60.08% |
| Dec 30, 2022 | 397.29M | -62.10% |
| Dec 31, 2021 | 1.05B | -61.94% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 25, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Equillium | 108.43M |
| Conexeu Sciences | 108.17M |
| PolyPid | 107.65M |
| Black Diamond Therapeutics | 106.58M |
| Tenax Therapeutics | 106.54M |
| Nutriband | 103.44M |
| Cellectis | 103.39M |
| Polaryx Therapeutics | 102.18M |